Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease

Documenti analoghi

• Reply to the letter to the editor “chronic disseminated candidiasis” by Kenneth Rolston
  di: Della Pepa, Roberta, et al.
  Pubblicazione: (2017)
• Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience
  di: Cerchione, Claudio, et al.
  Pubblicazione: (2016)
• Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
  di: Wu, Dijiong, et al.
  Pubblicazione: (2018)
• Deferasirox for managing iron overload in people with myelodysplastic syndrome
  di: Meerpohl, Joerg J, et al.
  Pubblicazione: (2014)
• Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload
  di: Aydinok, Yesim, et al.
  Pubblicazione: (2015)